science

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

NYT > Science·September 30, 2026

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Read Full Article on NYT > Science →

More from Science

Viper Image That Caused Alarm in California Was A.I.-Generated
NYT > Science
New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
NYT > Science
Cannabis users were twice as likely to commit violence, review finds
Latest Science News -- ScienceDaily